Literature DB >> 2986056

Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients.

L Pique, S Jegou, X Bertagna, F Javoy-Agid, D Seurin, M F Proeschel, F Girard, Y Agid, H Vaudry, J P Luton.   

Abstract

The concentrations of gamma 3-melanotropin-, alpha-melanotropin-, corticotropin-, gamma-lipotropin- and beta-endorphin-immunoreactivities were determined simultaneously, before and after gel exclusion chromatography, in whole hypothalamic extracts of normal subjects and Parkinson patients. All five immunoreactivities were present and were all significantly correlated to each other. Shorter peptides (alpha-melanotropin, gamma 3-melanotropin, beta-endorphin and a lipotropin37-58-like peptide) were the dominant products. Whereas the dopamine content was significantly reduced in Parkinson patients, there was no significant difference for any peptide between normal subjects and Parkinson patients, either in tissue concentrations or in chromatographic patterns.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986056     DOI: 10.1016/s0304-3940(85)80069-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Pineal melatonin and sensory symptoms in Parkinson disease.

Authors:  R Sandyk
Journal:  Ital J Neurol Sci       Date:  1989-08

Review 2.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

Review 3.  The hypothalamus in MPTP-induced parkinsonism.

Authors:  R Sandyk; R P Iacono; S R Kay
Journal:  Ital J Neurol Sci       Date:  1990-08

4.  Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries.

Authors:  Y de Keyzer; X Bertagna; F Lenne; F Girard; J P Luton; A Kahn
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

5.  Human beta-melanocyte-stimulating hormone revisited.

Authors:  X Bertagna; F Lenne; D Comar; J F Massias; H Wajcman; V Baudin; J P Luton; F Girard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 6.  Dopamine: A Modulator of Circadian Rhythms in the Central Nervous System.

Authors:  Kirill S Korshunov; Laura J Blakemore; Paul Q Trombley
Journal:  Front Cell Neurosci       Date:  2017-04-03       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.